https://www.selleckchem.com/pr....oducts/nec-1s-7-cl-o
8 vs. 0.8%; p=0.0004) as well as for the p.T790M resistance mutation (median MAFs=8.69 vs. 0.16%; p=0.039. Importantly, two patients who had progressed on first-generation -tyrosine kinase inhibitors with a dubious result for p.T790M plasma (MAFs=0.11%) had an indisputably positive result in their respective body fluid samples (MAFs=10.25 and 9.66%). ctDNA derived from body fluids is an informative source for biomarker testing, with greater sensitivity than plasma samples. ctDNA derived from body fluids is an informative so
Like
Comment
Share
